Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Autor:
Crown, Angelena, Joseph, Kathie-Ann
Publikováno v:
Current Breast Cancer Reports; Dec2022, Vol. 14 Issue 4, p162-167, 6p
Autor:
Oakman, Catherine, Tenori, Leonardo, Cappadona S, Silvia, Luchinat, Claudio, Bertini, Ivano, Leo, Angelo
Publikováno v:
Current Breast Cancer Reports; Dec2012, Vol. 4 Issue 4, p249-256, 8p
Autor:
Chauviere, Arnaud, Hatzikirou, Haralampos, Lowengrub, John, Frieboes, Hermann, Thompson, Alastair, Cristini, Vittorio
Publikováno v:
Current Breast Cancer Reports; Sep2010, Vol. 2 Issue 3, p121-129, 9p
Publikováno v:
Current Breast Cancer Reports
Oncoplastic surgery is integral to all breast cancer surgeries. The use of an aesthetic approach to breast conservation or mastectomy greatly enhances the range of options that can be offered to women with breast cancer and facilitates better outomes
Publikováno v:
Current Breast Cancer Reports
Random periareolar fine needle aspiration (RPFNA) and ductal lavage (DL) are research techniques developed to (1) assess short-term breast cancer risk in asymptomatic women who are at increased risk for breast cancer and (2) track cytological respons
Publikováno v:
Current Breast Cancer Reports
Flanagan, Meghan; Love, Susan; & Hwang, E. Shelley. (2010). Status of Intraductal Therapy for Ductal Carcinoma in Situ. Current Breast Cancer Reports, 2(2), pp 75-82. doi: 10.1007/s12609-010-0015-3. Retrieved from: http://www.escholarship.org/uc/item/461925s9
Flanagan, Meghan; Love, Susan; & Hwang, E. Shelley. (2010). Status of Intraductal Therapy for Ductal Carcinoma in Situ. Current Breast Cancer Reports, 2(2), pp 75-82. doi: 10.1007/s12609-010-0015-3. Retrieved from: http://www.escholarship.org/uc/item/461925s9
The intraductal approach is particularly appealing in the setting of ductal carcinoma in situ (DCIS), a preinvasive breast neoplasm that is thought to be entirely intraductal in its extent. Based on an emerging understanding of the anatomy of the duc
Autor:
Jonas Bergh, Nicholas P. Tobin
Publikováno v:
Current Breast Cancer Reports
The oncogenic capabilities of the cell cycle protein cyclin D1 have long been established in a breast cancer setting. The CCND1 gene is amplified in up to 15 % of breast tumors, with overexpression of its corresponding protein found in up to 50 % of